Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection

BACKGROUND AND AIMS: The coronavirus disease 2019 (COVID-19) number of death cases is still increasing. One of the comorbidities associated with severe outcome and mortality of COVID-19 is dyslipidemia. Statin is one of the drugs which is most commonly used for the treatment of dyslipidemic patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariyanto, Timotius Ivan, Kurniawan, Andree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448951/
https://www.ncbi.nlm.nih.gov/pubmed/32882643
http://dx.doi.org/10.1016/j.dsx.2020.08.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448951/
https://www.ncbi.nlm.nih.gov/pubmed/32882643
http://dx.doi.org/10.1016/j.dsx.2020.08.023

Ejemplares similares